Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Surviving Thomas Sweeney – CFO

Surviving Thomas Sweeney – CFO

posted on Apr 18, 2007 11:34AM

I know this is old Feb 28 news so I’ll be brief.

<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:of... />

If each member of this forum was asked to provide a plan of how they could determine the appropriate “accounting treatment” of a new company asset I’d expect it would take you 5 minutes to outline your plan – no matter what your background or education.

So why has PTSC’s CFO waited until Feb 28 to seek help on a subject that he is supposed to be an expert in? Is he incompetent (he’s missed financial deadlines before) or is there a hidden agenda – like getting past the stock holder meeting before showing what a great investment they made.

The registrant respectfully requests an extension of time to file its quarterly report on Form 10-Q for the period ended February 28, 2007 in order to obtain business information and to determine the appropriate accounting treatment for the registrant's recent investment in an affiliated company.

Share
New Message
Please login to post a reply